Physiologically Based Pharmacokinetic (PBPK) Modeling Solutions

Although formally launched in late 2020 as a key service offering within Parexel’s Clinical Pharmacology, Modeling and Simulation group, the development and utility of PBPK modeling throughout the drug development process is not new to Parexel.

Using industry standard software platforms coupled with Parexel’s integrated data management and quality systems, our experienced team of modelers will work with you to deepen your mechanistic understanding of your drug, mitigate risks by exploring the potential for critical drug-drug interactions or determine the selection of doses for first-time in a pediatric population. 

Engage Parexel’s CPMS team as your in silico drug development partner.  Our numerous strategies in modeling and simulation, including PBPK analysis, will help your drug development stay patient-centric by helping to minimize the number of patient exposures while supporting key clinical decisions.